Acute effect of 17β-estradiol and lithium on ovariectomized rat brain biogenic amines metabolism

Journal of Psychiatric Research

Volumn 30, Issue 2, 1996, Pages 95-107

  Morissette, Marc ^b   Di Paolo, Thérèse ^a  

^a LAVAL UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; BIOGENIC AMINE; BRAIN AMINE; DOPAMINE; ESTRADIOL; HOMOVANILLIC ACID; INDOLEAMINE; LITHIUM; LITHIUM CHLORIDE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; CATECHOLAMINE BRAIN LEVEL; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINE METABOLISM; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; FEMALE; FRONTAL CORTEX; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029938485     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-3956(95)00037-2     Document Type: Article

References (25)

1. Anden, N. E., Grabowska-Anden, M. & Liljenkerg, B. (1983). Demonstration of autoreceptor on dopamine neurons in different brain regions of rats treated with gammabutyrolactone. Journal of Neural Transmission. 58, 143-152.
2. Baptista, T., Teneud, L., Contreras, Q., Burguera, J. L., Burguera, M. & Hernandez, L. (1993). Effects of acute and chronic lithium treatment on amphetamine-induced dopamine increase in the nucleus accumbens and prefrontal cortex in rats as studied by microdialysis. Journal of Neural Transmission, 94, 75-89.
3. Berggren, U. (1985). The effect of acute lithium administration on brain monoamine synthesis and the precursor aminoacids tyrosine and tryptophane in brain and plasma in rats. Journal of Neural Transmission, 61, 175-181.
4. Biegon, A., Reches, A., Snyder, L. & McEwen, B. S. (1983). Serotonergic and noradrenergic receptors in the rat brain: modulation by chronic exposure to ovarian hormones. Life Sciences, 32, 2015-2021.
5. Bloom, F. E., Baetge, G., Deyo, S., Ettenberg, A., Koda, L., Magistretti, P. J., Shoemaker, W. J. & Staunton, D. A. (1983). Chemical and physiological aspects of the actions of lithium and antidepressant drugs. Neuro-pharmacology, 22, 359-365.
6. Carli, M., Anan-Srivastava, M. B., Molina-Holgado, E., Dewar, K. M. & Reader, T. A. (1994). Effects of chronic lithium treatments on central dopaminergic receptor systems: G proteins as possible targets. Neurochemistry International, 24, 13-22.
7. Crowley, W. R., O'Donohue, T. L., Muth, E. A. & Jacobowitz, D. M. (1979). Effects of ovarian hormones on levels of luteinizing hormone in plasma and on serotonin concentrations in discrete brain nuclei. Brain Research Bulletin, 4, 571-574.
8. deMontigny, C., Cournoyer, G., Morissette, R., Langlois, R. & Caille, G. (1983). Lithium carbonate addition in tricyclic antidepressant-resistant depression: correlation with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system. Archives of General Psychiatry, 40, 1327-1334.
9. Di Paolo, T. (1994). Modulation of brain dopamine transmission by sex steroids. Reviews in the Neuroscience, 5, 27-42.
10. Di Paolo, T., Bédard, P. J., Daigle, M. & Boucher, R. (1986). Long-term effects of MPTP on central and peripheral catecholamine and indoleamine concentrations in monkeys. Brain Research, 379, 286-293.
11. Di Paolo, T., Rouillard, C. & Bédard, P. J. (1985). 17β-estradiol at a physiological dose acutely increases dopamine turnover in rat brain. European Journal of Pharmacology, 117, 197-203.
12. Engel, J. & Berggren, U. (1980). Effects of lithium on behavior and central monoamines. Acta Psychiatric Scandinavica, Suppl. 280, 133-143.
13. Goodnick, P. J. & Gershon, S. (1985). Lithium. In Lajtha, A. (Ed.). Handbook of Neurochemistry. Alterations of Metabolites in the Nervous System, 103-149: Plenum Press, New York.
14. Gottberg, E., Grondin, E. & Reader, T. A. (1989). Acute effects of lithium on catecholamines, serotonin, and their metabolites in discrete brain regions. Journal of Neuroscience Research, 22, 338-345.
15. Häfner, H., Maurer, K., Löffler, W., Fätkenheuer, B., An der Heiden, W., Riecher-Rössler, A., Behrens, S. & Gattaz, W. F. (1994). The epidemiology of early schizophrenia. Influence of age and gender on onset and early course. British Journal of Psychiatry, 164, 29-38.
16. Jefferson, J. W., Greist, J. H., Ackerman, D. L. & Carroll, J. A. (1987). Lithium Encyclopedia for Clinical Practice American Psychiatric Press, Washington, DC.
17. Lévesque, D. & Di Paolo, T. (1988). Rapid conversion of high to low striatal D2-dopamine receptor agonist binding states after an acute physiological dose of 17β-estradiol. Neuroscience Letters, 88, 113-118.
18. Lowry, O. H., Rosenbrough, N. J., Farr, A. L. & Randall, R. J. (1951). Protein measurement with folin reagent. Journal of Biological Chemistry, 193, 265-272.
19. Otero-Losada, M. E. & Rubio, M. C. (1985). Striatal dopamine and motor activity changes observed shortly after lithium administration. Naunyn Schmiedebergs Archives of Pharmacology, 330, 169-174.
20. Price, L. H., Charney, D.S., Delgado, P. L. & Heninger, G. R. (1990). Lithium and serotonin function: implications for the serotonin hypothesis of depression. Psychopharmacology, 100, 3-12.
21. Riecher-Rössler, A., Häfner, H., Stumbaum, M., Maurer, K. & Schmidt, R. (1994). Can estradiol modulate schizophrenic symptomatology? Schizophrenia Bulletin, 20, 203-214.
22. Smith, D. F. (1980). Lithium and motor activity of animals: effects and possible mechanism of action. International Pharmacopsychiatry, 15, 197-217.
23. Thau, K., Rappelsberger, P., Loviek, A., Petsche, H., Simhandl, C. H. & Topitz, A. (1988). Effect of lithium on the EEG of healthy males and females. Neuropsychobiology, 20, 158-163.
24. Wolf, M. E., Galloway, M. P. & Roth, R. H. (1986). Regulation of dopamine synthesis in the medial prefrontal cortex: studies in brain slices. Journal of Pharmacology and Experimental Therapeutics, 236, 699-707.
25. Wood, A. J. & Goodwin, G. M. (1987). A review of the biochemical and neuropharmacological actions of lithium. Psychological Medicine, 17, 579-600.